Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2011.03.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection
2016English

Myelodysplastic Syndromes: Histopathology as Prognostic Factor

Revista Brasileira de Hematologia e Hemoterapia
2001English

Improving Prognostic Tools for Patients With Myelodysplastic Syndromes

Mayo Clinic Proceedings
Medicine
2018English

Prognostic Role of TET2 Deficiency in Myelodysplastic Syndromes: A Meta-Analysis

Oncotarget
Oncology
2017English

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Myelodysplastic Syndromes

Cancer
Cancer ResearchOncology
2007English

Myelodysplastic Syndromes

2004English

Myelodysplastic Syndromes

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy